The World Economic Forum has published the annual list of Technology Pioneers. Two of the 14 companies chosen in the category of Life Sciences & Health are Israeli: Consumer Physics and ElMindA.
The World Economic Forum's Technology Pioneers programme recognizes early-stage companies from around the world that are involved in the design, development and deployment of new technologies, and are poised to have a significant impact on business and society. Technology Pioneers come from a wide range of sectors such as life sciences and health, energy and environment, and information technologies and new media.
The World Economic Forum has published the annual list of Technology Pioneers, which this year consists of 49 companies from 10 countries, recognizing the world's 49 most promising Technology Pioneers for 2015. Two of the 14 companies chosen in the category of Life Sciences & Health are Israeli: Consumer Physics and ElMindA.
Consumer Physics, founded in 2011 and based in Herzliya, has produced the SCiO - a tiny spectrometer that allows you to get instant relevant information about the chemical make-up of just about anything around you, sent directly to your smartphone. The world's first molecular sensor that fits in the palm of your hand, it allows users to explore objects by scanning materials.
For example, you can:
Get nutritional facts about different kinds of food: Dairy products, Fruits and vegetables. Other apps for drinks, meats, ripeness, salad dressing and more will be released on a regular basis as our database expands.
Know the well-being of popular plants.
Identify capsules containing medicine and nutritional supplements.
Help build the world's first database of matter.
Potential future use cases include analysis of pharmaceuticals, nutritional supplements, cosmetics, textiles, plants, gemstones, rubber, plastics, and the human body.
ElMindA, also based in Herzliya, was founded in 2006, with the vision of revolutionizing the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice.
ElMindA Ltd. has developed Brain Network Activation (BNA), a non-invasive technology that allows physicians to accurately differentiate between the function of a healthy brain and the dysfunction of an injured brain. With BNA physicians can monitor change in brain networks and address brain health by identifying disease onset and assessing treatment efficacy. ElMindA is revolutionizing our ability to assess and treat the brain across a broad range of previously elusive conditions such as depression, pain, or memory loss.
ElMindA’s innovative approach and supporting data have led to partnerships with top pharmaceutical companies and leading neurological and psychiatric institutes around the world. The company has already completed several clinical trials establishing the utility of the BNA™ technology, and its technology is already being utilized by leading pharmaceutical companies as an integral part of their clinical development programs for monitoring drug effect on the brain.
BNA™ as a measure of brain state and brain changes, can potentially be applied to a wide spectrum of indications and their therapeutic interventions including Alzheimer’s disease, Parkinson’s disease, Concussion, ADHD, pain, stroke, depression, and other Central Nervous System related conditions. In addition, the technology serves as a valuable tool in the development of CNS related treatments.
Photo: Israel's Technological Pioneers: Consumer Physics and ElMindA
Copyright: World Economic Forum Technology Pioneers